Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
August 28, 2012 · Comments Off
Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.
University of Colorado Cancer Center researcher recognized in quest to eradicate lung cancer
June 8, 2012 · Comments Off
Ross Camidge, MD, PhD, recipient of Addario Lectureship Award An investigator for the University of...
Low testosterone with new lung cancer drug — if recognized, easy to fix
April 5, 2012 · Comments Off
Men experience a marked drop in their testosterone levels when taking a targeted therapy to...
Cancer survivor to test lungs at Livestrong Austin Half Marathon
February 15, 2012 · Comments Off
For lung cancer survivor Matt Ellefson, the Livestrong Austin Half Marathon is about more than...
People with specific kind of lung cancer respond to new targeted treatment
October 28, 2010 · Comments Off
A study in the New England Journal of Medicine shows more than half of patients...
UCCC offers ALK positive lung cancer clinical trial
February 19, 2010 · Comments Off
Learn more about the trial Aurora, Colo. (Feb. 19 2010) — The University of Colorado...
NTRK1: a new oncogene and target in lung cancer
February 19, 2010
A diet of resistant starch helps the body resist colorectal cancer
February 19, 2010
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
New tool developed at the CU Cancer Center helps doctors identify patients at highest risk of mortality --... http://t.co/RG1VMhAfyo
If you were planning to attend either our brain tumor support group at University of Colorado Hospital or our... http://t.co/Wsbl49jxag
New Cancer Center study shows active component of grape seed extract effective against cancer cells. http://t.co/nq2Cfar6an
C3 Magazine: Collaborating to Conquer Cancer Fall edition is here. Read stories about fingerprinting cancer, a... http://t.co/ce9xjCSHBi